Mar 20 |
CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration
|
Mar 18 |
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
|
Mar 4 |
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair
|
Jan 29 |
Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology
|
Dec 21 |
One CytoMed Therapeutics Insider Raised Stake By 46% In Previous Year
|
Dec 5 |
CytoMed signs agreements to advance research on allogeneic gamma delta T cell technology
|
Dec 5 |
CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology
|
Nov 17 |
CytoMed Therapeutics Limited reports 1H results
|
Nov 17 |
CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update
|
Nov 14 |
CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference
|